Company News

Share this article:

McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, announced the launch of two new Zyrtec formulations: Zyrtec Perfect Measure (pre-filled spoons of children's Zyrtec) and Zyrtec Itchy Eye Drops. Zyrtec transitioned from prescription medication to OTC in January 2008. Prescription Zyrtec was originally licensed from UCB by Pfizer.

MediciNova, a California-based biopharma, announced that it will acquire Avigen, a biopharma focused on gene-based therapeutic products for neurological and other disorders, in a deal valued at $37 million, according to several reports. Both companies are working on the development of ibudilast, an anti-inflammatory product with several potential uses in the neurological area.


Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.